Literature DB >> 18187076

Carotid artery intima-media thickness in nonalcoholic fatty liver disease.

Anna Ludovica Fracanzani1, Larry Burdick, Sara Raselli, Paola Pedotti, Liliana Grigore, Gennaro Santorelli, Luca Valenti, Alessandra Maraschi, Alberico Catapano, Silvia Fargion.   

Abstract

PURPOSE: To evaluate, in patients with nonalcoholic fatty liver disease with no or mild alterations of liver function tests, carotid artery intima-media thickness and the presence of plaques and to define determinants of vascular damage.
METHODS: A paired-sample case-control study: 125 patients with nonalcoholic fatty liver disease and 250 controls, without a prior diagnosis of diabetes, hypertension, and cardiovascular disease, matched for sex, age, and body mass index. B-mode ultrasound was used for evaluation of carotid intima-media thickness and presence of small plaques.
RESULTS: A significant difference in mean values of intima-media thickness (0.89+/-0.26 and 0.64+/-0.14 mm, P = .0001) and prevalence of plaques (26 [21%] and 15 [6%], P < .001) was observed in nonalcoholic fatty liver disease patients and controls. Variables significantly associated with intima-media thickness higher than 0.64 mm (median value in controls), in both patients and controls were: age (P = .0001), systolic blood pressure (P = .004), total and low-density lipoprotein cholesterol (P < or = .02 and P = .01, respectively), fasting glucose (P = .0001), and cardiovascular risk (P = .0001) and, only in controls, metabolic syndrome (P = .0001), HOMA-insulin resistance (P = .01), and body mass index (P = .0003). At multivariate logistic regression performed in the overall series of subjects, independent risk predictors of intima-media thickness higher than 0.64 mm were presence of steatosis (odds ratio [OR] = 6.9), age (OR 6.0), and systolic blood pressure (OR 2.3).
CONCLUSION: Patients with nonalcoholic fatty liver disease, even with no or mild alterations of liver tests, should be considered at high risk for cardiovascular complications.

Entities:  

Mesh:

Year:  2008        PMID: 18187076     DOI: 10.1016/j.amjmed.2007.08.041

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  62 in total

1.  Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis.

Authors:  Jia Cai; Shujun Zhang; Wenxiang Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 3.  Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

Authors:  Enzo Bonora; Giovanni Targher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-08       Impact factor: 46.802

4.  Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease.

Authors:  Ivana Mikolasevic; Lidija Orlic; Sandra Milic; Vesna Lukenda; Sanjin Racki; Davor Stimac; Ervin Avdovic; Luka Zaputovic
Journal:  Wien Klin Wochenschr       Date:  2014-03-21       Impact factor: 1.704

5.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

6.  Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.

Authors:  Radojica V Stolic; Goran Z Trajkovic; Mirjana M Kostic; Sasa R Sovtic; Andrijana M Odalovic; Biljana D Krdzic; Maja V Sipic; Snezana Lazic; Zorica N Sojevic-Timotijevic
Journal:  Int Urol Nephrol       Date:  2016-02-23       Impact factor: 2.370

Review 7.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

Review 8.  Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

Authors:  Hilmar K Lückhoff; Frederik C Kruger; Maritha J Kotze
Journal:  World J Hepatol       Date:  2015-05-28

9.  Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease.

Authors:  Guldem Kilciler; Halil Genc; Serkan Tapan; Fatih Ors; Muammer Kara; Nuri Karadurmus; C Nuri Ercin; Yildirim Karslioglu; Selim Kilic; Sait Bagci; M Kemal Erbil; Teoman Dogru
Journal:  Ups J Med Sci       Date:  2010-08-23       Impact factor: 2.384

Review 10.  Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

Authors:  G Targher; F Marra; G Marchesini
Journal:  Diabetologia       Date:  2008-09-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.